Home | Welcome to Contract Pharma   
Last Updated Saturday, August 30 2014
Print

2009 Top 20 Pharmaceutical Companies Report



They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top!



Published July 15, 2009

2009 Top 20 Pharmaceutical Companies Report



They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top!

It’s a good thing my “Pharm System” has a whole crop of new companies to move into the ranks — you're on deck, Gilead! — but how will all these mergers and consolidations affect contract service providers? Columnist Michael Martorelli has some thoughts on the subject in this issue, but pharma companies remain quiet about how they’ll reconcile their internal mega-networks with their outsourcing strategies. So stay tuned . . .

Gil Y. Roth, Editor

 

Top 20 Pharmaceutical Companies
01 Pfizer $44,174
02 Sanofi-Aventis $40,562
03 GlaxoSmithKline $37,810
04 Novartis $35,647
05 AstraZeneca $30,677
06 Merck $25,901
07 Johnson & Johnson $24,567
08 Roche $23,624
09 Eli Lilly & Co. $19,285
10 Bristol-Myers Squibb $17,715
11 Wyeth $17,391
12 Schering-Plough $16,534
13 Abbott Laboratories $16,013
14 Takeda $13,841
15 Bayer Schering $13,803
16 Boehringer Ingelheim $13,405
17 Teva* 10,482
18 Astellas* $9,646
19 Daiichi-Sankyo* $7,900
20 Eisai* $7,612

Based on 2008 pharma revenues.
Note: In all Top Company profiles, dollar amounts are in millions.
For the pipeline and patent expiry info, download the PDFs of the profiles, available within each company's page.

* PDF profiles only available for companies 17-20

 

Contributors


Editor: Gil Y. Roth
Associate Editor: Kristin Brooks
Contributing Editor: Derek B. Lowe

All profiles written by Gil Roth, except Bayer-Schering, by Kristin Brooks.

The Lowe Down capsules written by Derek Lowe

All pipeline information compiled by Kristin Brooks

Sales information compiled by Gil Roth

Looking for the Top 10 Biopharma companies report? Look no further!



blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On